Emeis (ORPEF) Change In Receivables: $-161 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ORPEF Emeis ORPEF
53 GF Score
Price $14.22
GF Value $9.45
! 8 Warning Signs
View Full Analysis

What is Emeis Change In Receivables?

Emeis ORPEF 53 Change In Receivables is $-161 Mil as of Dec. 2025. GuruFocus rates ORPEF with a GF Score™ of 53/100 and a GF Value™ of $9.45. The stock has 8 warning signs investors should review.

Emeis's change in receivables for the quarter that ended in Dec. 2025 was $36 Mil. It means Emeis's Accounts Receivable declined by $36 Mil from Jun. 2025 to Dec. 2025 .

Emeis's change in receivables for the fiscal year that ended in Dec. 2025 was $-164 Mil. It means Emeis's Accounts Receivable increased by $164 Mil from Dec. 2024 to Dec. 2025 .

Emeis's Accounts Receivable for the quarter that ended in Dec. 2025 was $779 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Emeis's Days Sales Outstanding for the six months ended in Dec. 2025 was 40.66.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Emeis's liquidation value for the six months ended in Dec. 2025 was $-12,180 Mil.

Emeis  (OTCPK:ORPEF) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Emeis's Days Sales Outstanding for the quarter that ended in Dec. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=779.3/3497.891*91
=40.66

2. In Ben Graham's calculation of liquidation value, Emeis's accounts receivable are only considered to be worth 75% of book value:

Emeis's liquidation value for the quarter that ended in Dec. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=394.721-13167.501+0.75 * 779.3+0.5 * 17.171
=-12,180

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Emeis Change In Receivables Related Terms

Emeis Change In Receivables Historical Data

* Premium members only.

The historical data trend for Emeis's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Emeis Change In Receivables Chart

Emeis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -233.26 23.15 -171.02 41.73 -164.25

Emeis Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -151.16 -263.39 297.95 -197.67 36.43
ORPEF
53GF Score
Emeis ORPEF
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Emeis Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-161 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of $-161 Mil mean?
Emeis (ORPEF) has a Change In Receivables of $-161 Mil as of Dec. 2025. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Emeis and its competitors.
Is Emeis' Change In Receivables too high?
Emeis' current Change In Receivables is $-161 Mil. Overall, Emeis has a GF Score™ of 53/100, reflecting its overall financial health beyond just this single metric.
How does Emeis' Change In Receivables compare to HCA and THC?
Emeis' Change In Receivables of $-161 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Healthcare Providers & Services company?
A good Change In Receivables depends on the Healthcare Providers & Services industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Emeis and its competitors. Emeis's current Change In Receivables is $-161 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Emeis stock overvalued right now?
Emeis (ORPEF) has a current Change In Receivables of $-161 Mil. The stock's GF Value™ is $9.45, compared to a current price of $14.22 — trading 50.5% above its estimated fair value. The current Change In Receivables is $-161 Mil. Emeis' overall GF Score™ is 53/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Emeis (ORPEF), the current Change In Receivables is $-161 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Emeis (ORPEF) Overvalued in 2026?

Based on GuruFocus' analysis, Emeis stock appears to be overvalued. The current stock price of $14.22 is trading 50.5% above its estimated GF Value™ of $9.45.

Key valuation signals for ORPEF:

  • Change In Receivables: $-161 Mil
  • GF Value™: $9.45 vs. price of $14.22 (50.5% above fair value)
  • GF Score™: 53/100 with 8 warning signs

No single metric tells the full story. See the ORPEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Emeis Business Description

Address 12, Rue Jean Jaures, CS 10032, Puteaux Cedex, Paris, FRA, 92 813
Emeis operates a comprehensive care offering of mental health clinics and medical and rehabilitation care, retirement homes, assisted living and home care.
53GF Score

Get the complete analysis for ORPEF

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.22
Price
$9.45
GF Value